UBS O'Connor’s Align Technology ALGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,755
Closed -$2.41M 281
2025
Q2
$2.41M Buy
12,755
+3,705
+41% +$655K 0.07% 141
2025
Q1
$1.44M Buy
9,050
+1,800
+25% +$353K 0.03% 152
2024
Q4
$1.51M Buy
7,250
+1,800
+33% +$402K 0.04% 188
2024
Q3
$1.39M Buy
5,450
+3,416
+168% +$806K 0.03% 238
2024
Q2
$491K Buy
+2,034
New +$566K 0.01% 368
2023
Q4
Sell
-5,300
Closed -$1.62M 510
2023
Q3
$1.62M Buy
5,300
+409
+8% +$141K 0.03% 270
2023
Q2
$1.73M Sell
4,891
-234
-5% -$74.5K 0.04% 323
2023
Q1
$1.71M Sell
5,125
-5,949
-54% -$1.76M 0.04% 349
2022
Q4
$2.34M Buy
+11,074
New +$2.22M 0.04% 430

Other funds holding ALGN

UBS O'Connor's ALGN Position: Q3 2025 in Review

UBS O'Connor sold out of Align Technology (ALGN) in Q3 2025, closing a stake of 12,755 shares — an estimated $2.41M sold.

UBS O'Connor first reported a position in ALGN in Q4 2022 and held it in 9 quarters. The position peaked at $2.41M in Q2 2025. 668 funds tracked by Wall St. Rank hold ALGN as of Q3 2025.

  • UBS O'Connor reported no remaining Align Technology position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 12,755 Align Technology shares in Q3 2025, an estimated $2.41M.
  • UBS O'Connor first reported a position in Align Technology in Q4 2022 and held it in 9 quarters.
  • UBS O'Connor's Align Technology position peaked at $2.41M in Q2 2025.
  • 668 funds tracked by Wall St. Rank held Align Technology as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.